Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News

Icon

Sanofi Ventures leads $17M investment in Click Therapeutics, finalist @ 2017 Brainnovations Pitch Contest

___

Sanofi Backs Click Ther­a­peu­tics as Dig­i­tal Med­i­cines Gain Momen­tum (Xcon­o­my):

Drug mak­ers are mak­ing more bets on the nascent field of dig­i­tal med­i­cine. The lat­est exam­ple: Click Ther­a­peu­tics announced Mon­day that it grabbed a $17 mil­lion invest­ment led by Sanofi Ven­tures, the Cam­bridge, MA-based ven­ture cap­i­tal arm of the French phar­ma­ceu­ti­cal giant. Read the rest of this entry »

Lifestyle and neurotechnology over genetics

Dear col­league,

It’s remark­able how quick­ly things are chang­ing, final­ly, in brain health and men­tal health — see for exam­ple what’s new with Inter­ax­on, Akili, Neu­raMetrix, Apple, Calm, Halo Neu­ro­science, Mind­strong Health, Novar­tis, Pear Ther­a­peu­tics, and life­long neu­ro­ge­n­e­sis, all in the last 6 months!

Please enjoy the May edi­tion of Sharp­Brains eNewslet­ter below, and con­sid­er join­ing the Sharp­Brains Vir­tu­al Sum­mit this Decem­ber to dis­cuss the lat­est and help shape the next 🙂

New research:

New tools:

 

Have a great month of June,

 

The Sharp­Brains Team

Reinventing Brain Medicine, Pharma adopts Digital Therapeutics: Evidence-based videogames, smartphone apps, and sensors

___

From app store to drug store, dig­i­tal health is redefin­ing pharma’s pipeline (STAT):

The pitch­es always sound­ed promis­ing: A new soft­ware app could track glu­cose lev­els for peo­ple with dia­betes or soothe the brains of insom­ni­acs. Most phar­ma exec­u­tives would polite­ly smile and nod, but then park their mon­ey some­where else.

Not any­more. Read the rest of this entry »

Update: Why monitoring Typing Cadence may help detect early Parkinson’s and Alzheimer’s Disease

Above: Pat­tern of Typ­ing Cadence in 52-year-old male with Parkinson’s. Source: Neu­raMetrix

_____

Time for Sharp­Brains’ first eNewslet­ter in 2018, offer­ing a fas­ci­nat­ing sneek peek into the rapid­ly grow­ing toolk­it to mea­sure and improve brain health.

(And don’t miss the fun teas­er at the end!)

New thinking:

New research:

New tools:

 

 

Final­ly, a quick brain teas­er. What do you see first, ani­mals or peo­ple?

 

Have a great month of Feb­ru­ary!

Pear Therapeutics raises $50M to develop and market a portfolio of digital therapeutics for mental health

___

Pear Ther­a­peu­tics rakes in $50M to devel­op addi­tion­al dig­i­tal ther­a­peu­tics (Mobi­Health­News):

Boston- and San Fran­cis­co-based Pear Ther­a­peu­tics, mak­er of a pre­scrip­tion dig­i­tal ther­a­peu­tic plat­form, announced today the clo­sure of $50 mil­lion in Series B fund­ing. The round was led by Sin­ga­pore-based invest­ment com­pa­ny Temasek, with par­tic­i­pa­tion from return­ing investors 5AM Ven­tures, Arbore­tum Ven­tures, and JAZZ Ven­ture Part­ners, as well as new part­ners Novar­tis, EDBI, and the Bridge Builder’s Col­lab­o­ra­tive Read the rest of this entry »

About SharpBrains

As seen in The New York Times, The Wall Street Journal, BBC News, CNN, Reuters and more, SharpBrains is an independent market research firm tracking health and performance applications of brain science.

Follow us and Engage via…

twitter_logo_header
RSS Feed

Search for anything brain-related in our article archives

Enter Your Email to receive Sharp­Brains free, monthly eNewslet­ter:

Join more than 50,000 Sub­scribers and stay informed and engaged.